Antimicrobial susceptibility patterns of group B Streptococci isolated from pregnant women in Trinidad, West Indies.

F. A. Orrett

2004-11-01

Saudi Medical Journal

Abstract:roup B Streptococcus (GBS) is a common perinatal pathogen frequently associated with neonatal sepsis and meningitis with resultant high mortality in developing countries.1,2 The reservoir of GBS is the gastrointestinal tract with consequent colonization of the vagina, where the organisms are usually asymptomatic. Infants may therefore become infected through vertical transmission during birth from high risk mothers, such as those with premature delivery (<37 weeks gestation), intrapartum fever (temperature >380C) and prolonged rupture of membranes (>18hrs). Maternal carriage of GBS has been reported to be between 4.6-30% in developed countries such as the United States of America and the United Kingdom, with the incidence of neonatal infection varying between 0.3 and 5 per 1000 live births.3 Carriage rates among developing countries differ considerably with rates lower than some developed countries and significantly higher in others. Low carriage rates have been reported from Libya (5%) and India (5.8%),4 whereas, higher rates of colonization were documented from Trinidad, West Indies (31-33%).5 Group B Streptococcal neonatal and maternal diseases are potentially preventable. Studies have shown that intrapartum antibiotic prophylaxis decreases the incidence of neonatal GBS infection. Intrapartum ampicillin (rather than penicillin) prophylaxis to high-risk mothers has been recommended because of the former’s broader spectrum of activity. For persons allergic to the penicillins, clindamycin or erythromycin have been recommended. Recently, increasing resistance has been noted to clindamycin (3-13%) and erythromycin (7-15%) among GBS isolates, which has been associated with treatment failures. This study was undertaken to evaluate whether changes in GBS antimicrobial susceptibility has occurred in this modern era of liberal use of antimicrobial agents among third trimester pregnant women in Trinidad, West Indies. Rectal and vaginal isolates of GBS were obtained from 405 women in their third trimester of pregnancy during routine antenatal visits from July to August, 1992 and October, 2000 to March, 2001. One hundred and thirty strains of G confirmed GBS that were frozen at -200C were thawed and incubated at 35-370C for 18-24 hrs in Todd-Hewitt broth to confirm viability. Antimicrobial susceptibility testing to 9 antibiotics (Table 1) was carried out on Mueller-Hinton agar supplemented with 5% sheep blood, using the disk diffusion technique. From the 405 third trimester pregnant women, 32% (130/405) of them were colonized with GBS. All 130 GBS isolates were fully susceptible to ampicillin, amoxicillin-clavulanic acid and cephalothin (Table 1). The greatest prevalence of resistance was seen with tetracycline (93.8%) followed by gentamicin (90.8%) and trimethoprim-sulfamethoxazole (83.1%). Resistance rates to the other antibiotics: erythromycin, clindamycin and chloramphenicol were less than 8%. Intrapartum antibiotic administration has been shown to interrupt transmission of GBS from mother to infant. Group B Streptococcus has remained sensitive to the penicillins, particularly penicillin G and ampicillin. Penicillin G is preferred, but because of ampicillin’s wider spectrum of activity against both gram-positive and gram-negative bacteria, concerns have been expressed about increasing resistance to ampicillin among gram-negative organisms such as Escherichia coli and Enterobacter species. Also, treatment failure rates of up to 50% have been reported when penicillin G or ampicillin was used to